leisure time -WSS

leisure time

author：comprehensive 2025-09-29 08:50:58 - browse：2

The US Supreme Court silhouetted -- Abortion coverage from STAT — STEFANI REYNOLDS/AFP via Getty Images

WASHINGTON — The Supreme Court on Monday wrestled with a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids.

The justices seemed by turns relucant to break up an exhaustively negotiated agreement, but also leery of somehow rewarding the Sacklers.

The agreement hammered out with state and local governments and victims would provide billions of dollars to combat the opioid epidemic. The Sacklers would contribute up to $6 billion and give up ownership of the company, but retain billions more. The company would emerge from bankruptcy as a different entity, with its profits used for treatment and prevention.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Experts study whether long Covid risk adds up with each reinfection

hotspot

WSS

STAT Virtual Event: Putting AI to the Test

Medical student insurance fails on mental health care coverage

Measles policy set amid Florida outbreak alarms vaccine proponents

Biotech stock slump in 2023: awaiting the turnaround

Weight loss drugs aren’t covered by Obamacare. That may change

Weight loss drugs aren’t covered by Obamacare. That may change

Wikipedia

leisure time

entertainment

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

STAT Virtual Event: Putting AI to the Test

Supreme Court strikes down use of affirmative action

Secretariat’s lessons for human medicine

DIEP, the 'gold standard' of breast reconstruction, is under threat

FDA warns medical device makers about rise in fabricated data

Medical leaders decry Supreme Court decision on affirmative action

How AI helped researchers track recovery from depression

Heart attack and stroke risk calculators need revising

Ukraine seeks to reclaim its role as a hub for clinical trials

knowledge

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

STAT Virtual Event: Putting AI to the Test

Weight loss drugs aren’t covered by Obamacare. That may change

Senate HELP committee spars over health care workforce policies

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

focus

leisure time

hotspot

leisure time